Investigating therapeutic efficacy of dacarbazine and temozolomide, alone and in combination with <i>BRAF</i> <sup>(V600E)</sup> siRNA in A375 human melanoma cell line.

These findings suggest that the siRNA-transfected treatment groups have the potential to provide therapeutic effects comparable to those of chemotherapy.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2025-01-01
DOI
https://doi.org/10.22038/ijbms.2025.84187.18208
Primary Topic
Brain Metastases and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Investigating therapeutic efficacy of dacarbazine and temozolomide, alone and in combination with BRAF (V600E) siRNA in A375 human melanoma cell line.

Mohammadreza Sharifi, Fatemeh Tabandeh, Rana Moradian Tehrani, Elmira Toopchi
PubMed
Brain Metastases and Treatment
article

Investigating therapeutic efficacy of dacarbazine and temozolomide, alone and in combination with BRAF (V600E) siRNA in A375 human melanoma cell line.

Mohammadreza Sharifi, Fatemeh Tabandeh, Rana Moradian Tehrani, Elmira Toopchi
article en

Abstract

These findings suggest that the siRNA-transfected treatment groups have the potential to provide therapeutic effects comparable to those of chemotherapy.

PubMedVol. 28(6)
Isfahan University of Medical Sciences (IR)
Isfahan University of Medical Sciences
Openalex Percentile: Top 84%
Brain Metastases and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.